MALCOLM JAN 4

4 · UNITED THERAPEUTICS Corp · Filed Jul 28, 2025

Form 4

Period: 2025-06-26

Director

Transactions

Exercise/Conversion
Common Stock
[F1]
2025-06-26+630→ 630 total
Exercise/Conversion
Common Stock
[F2]
2025-07-25+590→ 1,220 total
Exercise/Conversion
Restricted Stock Unit
[F1][F2][F3]
2025-06-26−630→ 0 total
Exercise: $0.00From: 2025-06-26→ Common Stock (630 underlying)
Exercise/Conversion
Restricted Stock Unit
[F2][F3]
2025-07-25−590→ 0 total
Exercise: $0.00From: 2025-07-25→ Common Stock (590 underlying)
Award
Restricted Stock Unit
[F4][F5][F3]
2025-07-24+650→ 650 total
Exercise: $0.00From: 2026-07-09→ Common Stock (650 underlying)
Award
Stock Options
[F5]
2025-07-24+1,830→ 1,830 total
Exercise: $306.41From: 2026-07-09Exp: 2035-07-24→ Common Stock (1,830 underlying)

Footnotes (5)

[F1]Shares received upon vesting of restricted stock units on June 26, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock.
[F2]Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock.
[F3]Not applicable as restricted stock units do not have an expiration date.
[F4]Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
[F5]Annual non-employee director award.

Signature

/s/ John S. Hess, Jr. under Power of Attorney|2025-07-25

Documents

1 file